Annexon director reports Rule 10b5-1 stock purchase of 4,115 shares
Annexon, Inc. director reports open-market stock purchase under a Rule 10b5-1 plan.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Filing Summary
Annexon, Inc. director reports open-market stock purchase under a Rule 10b5-1 plan. On 12/01/2025, the reporting person bought 4,115 shares of Annexon common stock in a transaction coded as a purchase. The weighted average purchase price was $4.47 per share, with individual trades executed between $4.43 and $4.50.
After this transaction, the director beneficially owned 50,290 shares held directly. The filing notes that the trades were made pursuant to the director’s Rule 10b5-1 trading plan adopted on March 17, 2025, and the director has agreed to provide detailed trade information within the reported price range upon request.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Purchase | Common Stock | 4,115 | $4.47 | $18K |
Footnotes (2)
- F1. The transactions reported herein were effected pursuant to the Reporting Person's Rule 10b5-1 trading plan, adopted March 17, 2025.
- F2. This transaction was executed in multiple trades in prices ranging from $4.43 to $4.50, inclusive. The price reported in Column 4 above reflects the weighted average purchase price. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares purchased at each respective price within the range set forth in this footnote.
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What insider transaction did Annexon (ANNX) report in this Form 4?
Was the Annexon (ANNX) insider trade made under a Rule 10b5-1 trading plan?
Can investors get more detailed pricing information about the Annexon (ANNX) insider trades?
What is the relationship of the reporting person to Annexon (ANNX)?
AI-generated analysis. How Rhea-AI works. Not financial advice.